Delivery Order SPE2DB22D2206-SPE2DB24FEZ61
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The $2,367.00 order was awarded on January 17, 2024, with a completion date of January 18, 2024. This delivery order was placed under an existing contract with Amerisourcebergen Drug Corp, which has provided a range of pharmaceutical products and medical supplies to support...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,052.00, has a completion date of January 9, 2024. AmerisourceBergen Drug Corp is a prime contractor that has a long-standing relationship with DLA, providing a range of pharmaceutical and medical supplies to support military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.0.5ML. The $13,469.22 delivery order has a completion date of February 1, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $44,015.53 contract has an ultimate completion date of April 8, 2024 and is not associated with any set-aside designation. AmerisourceBergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $4,144.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, and no set-aside designation was used. Additionally, Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a $1,315.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp has received numerous prior federal contract awards from DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,400.00 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an active indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $3,818.76 and a period of performance through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) the company...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $1,160.72 firm fixed-price contract has an ultimate completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $1,052.00 delivery order has a period of performance through December 27, 2023 and does not include a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has an extensive history of providing pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEZ61Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,578.00 order has a completion date of January 9, 2024 and was not set aside for any special business category. Amerisourcebergen Drug Corp has a track record of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical programs. This order is part of Amerisourcebergen's broader indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/8/24 |